Advertising medical‑cannabis treatments violates the pharmaceutical‑advertising law. The Federal Court of Justice (BGH) ruled on Thursday that the operator of an internet platform that enables patients to request medical‑cannabis prescriptions from doctors has breached the prohibition on public advertising of prescription drugs. The complaint came from the Competitions Centre (Wettbewerbszentrale), which identified an infringement in the platform’s online presentation. First the Frankfurt Regional Court rejected the injunction, while the appellate court partially granted it. The defendant’s appeal at the BGH was unsuccessful. The court held that the website promoted medical cannabis and its uses in a way that was aimed at increasing sales, going beyond appropriate, factual information about possible therapies (judgment dated 26 March 2026 – I ZR 74/25).
Mixed
